Genetic Technologies Limi...

NASDAQ: GENE · Real-Time Price · USD
0.77
0.01 (0.65%)
At close: Nov 14, 2024, 10:00 PM

Genetic Income Statement

Financials in AUD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Revenue
7.66M 10.35M 6.79M 120.55K
Cost of Revenue
3.76M 4.34M 321.22K 361.03K
Gross Profit
3.9M 6.01M 6.47M -240.47K
Operating Income
-6.54M -10.42M -7.54M -7.42M
Interest Income
-272.12K 190.65K 36.26K 62.39K
Pretax Income
-12.02M -11.91M -7.16M -7.08M
Net Income
-12.02M -11.75M -7.13M -7.08M
Selling & General & Admin
12.83M 10.8M 4.07M 5.28M
Research & Development
752.75K 1.28M 705.51K 3.11M
Other Expenses
-9.67M 45.72K -1.49M 116.27K
Operating Expenses
3.9M 18.11M 3.11M 7M
Interest Expense
51.62K 29.52K 15.21K 14.05K
Selling & Marketing Expenses
2.61M 2.95M 1.89M 1.12M
Cost & Expenses
16.21M 22.45M 3.43M 7.36M
Income Tax Expense
n/a 158.33K -32.13K n/a
Shares Outstanding (Basic)
4.41M 112.53K 102.34K 94.84K
Shares Outstanding (Diluted)
4.41M 112.53K 102.34K 94.84K
EPS (Basic)
-2.73 -10.8 -6.96 -7.45
EPS (Diluted)
-2.73 -10.8 -6.96 -7.45
EBITDA
-11.43M -11.2M -7.2M -7.06M
EBIT
-11.97M -11.88M -7.15M -7.06M
Depreciation & Amortization
534.89K 676.58K 578.67K 478.22K